Pennant Group, Inc. 2026 Q1 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2026. The Pennant Group, Inc. is a holding company operating through independent subsidiaries providing healthcare services across the post-acute care continuum. As of the reporting date, the Company operated 174 home health, hospice, and home care agencies and 63 senior living communities across 16 states. The Company also provides operational support via a management service agreement in Connecticut.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Revenue | $285.4 million | $209.8 million |
| Net Income (GAAP) | $10.3 million | $8.5 million |
| Net Income Attributable to Pennant | $8.5 million | $7.8 million |
| Diluted EPS | $0.24 | $0.22 |
| Operating Income | $17.3 million | $12.7 million |
| Segment Adjusted EBITDAR | $53.1 million | $41.7 million |
| Cash and Cash Equivalents | $4.9 million | $5.2 million |
| Total Debt (Gross) | $170.8 million | $175.0 million |
| Available Revolver Capacity | $174.6 million | N/A |
| Net Cash Used in Operating Activities | ($3.4 million) | ($21.2 million) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 36.0% year-over-year. The Home Health and Hospice segment grew 43.3% (driven by 62.7% growth in home health admissions and 27.0% in hospice admissions), while Senior Living revenue grew 12.6%.
- Profitability: Operating margin improved slightly to 6.1% from 6.0%. Net income attributable to the Company increased 9.6%.
- Cost Structure: Cost of services increased 37.9% to $232.7 million, rising as a percentage of revenue from 80.4% to 81.5%. This was driven by increased volume and transition costs from acquisitions.
- Acquisitions: No acquisitions were completed in Q1 2026. However, revenue growth was significantly supported by operations acquired in late 2025 and early 2026.
- Liquidity: Cash on hand decreased to $4.9 million from $17.0 million at year-end 2025, primarily due to working capital changes and debt payments. However, the Company maintains $174.6 million in available revolver capacity.
Outlook, Risks, and Commentary
- Management Commentary: Management highlighted improved occupancy (78.6%) and revenue per occupied unit ($5,388) in Senior Living. Home Health and Hospice growth was attributed to increased admissions and census, bolstered by recent acquisitions.
- Regulatory Environment: The Consolidated Appropriations Act of 2026 extended telehealth waivers through December 2027 and prevented Medicare sequestration cuts. CMS proposed a 2.4% payment update for the 2027 Hospice Wage Index.
- Risks: Key risks include potential reductions in Medicare/Medicaid reimbursement rates, government audits and investigations (including False Claims Act exposure), and the impact of inflation on labor costs. A new risk factor regarding the regulatory and business risks of Artificial Intelligence was added.
- Subsequent Events: On April 1, 2026, the Company acquired real estate for one senior living community in Arizona for $2.0 million. On May 1, 2026, the Company entered into leases for three additional senior living communities (263 units) in Wisconsin and Arizona.
Investor Verification Checklist
- Verify the sustainability of the 36% revenue growth rate given the heavy reliance on acquisitions in the prior 12 months.
- Monitor the trend in Cost of Services as a percentage of revenue, which increased to 81.5% in Q1 2026.
- Review the Company's cash burn rate ($3.4M operating cash outflow) against its $4.9M cash balance and $174.6M revolver availability.
- Assess the impact of the new 2027 Hospice Payment Proposed Rule (2.4% update) on future margins.
- Track the status of ongoing Medicare/Medicaid audits and potential recoupments mentioned in the contingencies section.